Servier Laboratories

Servier is a privately owned pharmaceutical company with a long-standing commitment to research and development. 25% of turnover from Servier worldwide operations is channelled into research and development projects through the Servier Foundation.

Servier Australia's commercial interests include diabetes Nesina (alogliptin) & Nesina Met (alogliptin and metformin HCI), cardiovascular disease Coveram  (perindopril arginine/amlodipine), Coversyl (perindopril arginine), Coralan

(ivabradine) and in neuroscience, with products for major depression Valdoxan (agomelatine) and schizophrenia – Latuda (lurasidone)

View Site Show On Map